Acrivon Therapeutics Inc. Common Stock

ACRV | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.01

+$0.16 (+8.65%)

At close: Sep 21, 2026, 4:00 PM ET

$1.98

-$0.03 (-1.49%)

Pre-market: Sep 22, 2026, 8:13 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $86.03M

Enterprise Value $-1.81M

Beta 1.93

Average Volume 415.48K

Shares Outstanding (Diluted) 41.84M

Shares Change YoY 8.79%

Institutional Ownership 41.93%

Exchange NASDAQ

ISIN US0048901096

Price Performance

Price Change 1M -8.2%

Price Change 3M 23.3%

Price Change 6M 32.2%

Price Change YTD -18.3%

Price Change 1Y 21.1%

Price Change 3Y -78.5%

Price Change 5Y -87.3%

1M CAGR (ann.) 16.2%

1Y CAGR (ann.) 20.4%

5Y CAGR (ann.) N/A

All-Time CAGR -42.2%

Valuation

PE Ratio -1.07

Forward PE N/A

PEG Ratio -0.06

Forward PEG 0.17

PS Ratio N/A

Forward PS 517.40

PB Ratio 0.99

P/FCF Ratio -1.34

P/Adj. FCF Ratio -1.14

P/OCF Ratio -1.34

EV/Sales N/A

EV/EBIT 0.02

EV/EBITDA 0.02

EV/FCF 0.03

Earnings Yield -93.5%

FCF Yield -74.5%

Adj. FCF Yield -87.8%

Financial Health

Net Cash $87.84M

Total Debt $2.12M

Cash & Short-Term Investments $89.96M

Total Assets $99.09M

Current Ratio 7.99

Quick Ratio 7.99

Debt / Equity Ratio 0.02

Debt / EBITDA -0.03

Debt / FCF -0.03

OCF / Debt -29.75

Interest Coverage 0.00

Altman Z-Score -1.96

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -17.8%

Returns

Return on Assets -74.9%

Return on Equity -70.1%

Return on Invested Capital -88.3%

Return on Capital Employed -89.4%

Return on Tangible Assets -74.9%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 19.4%

EPS CAGR 5Y -11.5%

EPS CAGR 10Y N/A

FCF CAGR 3Y -6.9%

FCF CAGR 5Y -30.9%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 10

EPS Growth Next 3Y 11.7%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.45

EPS Growth Est (next Q) -4.3%

Revenue Est (next Q) $504.33K

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $21.83

Price Target Upside 986.1%

Cash Flow

Operating Cash Flow $-62.92M

Free Cash Flow $-64.14M

Adj. Free Cash Flow $-75.54M

FCF Per Share -$1.53

OCF Per Share -$1.50

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $528K

Operating Income $-78.37M

EBITDA $-78.94M

Net Income $-74.23M

EPS (Diluted) -$1.88

Revenue / Employee N/A

Profit / Employee $-989.67K

Employees 75